These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 26505835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A, Parmaksiz G, Dursun H, Ezer SS, Anarat R, Cengiz N.
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [Abstract] [Full Text] [Related]

  • 3. KIM-1 and NGAL: new markers of obstructive nephropathy.
    Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E.
    Pediatr Nephrol; 2011 Apr; 26(4):579-86. PubMed ID: 21279810
    [Abstract] [Full Text] [Related]

  • 4. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
    Pennemans V, Rigo JM, Faes C, Reynders C, Penders J, Swennen Q.
    Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
    [Abstract] [Full Text] [Related]

  • 5. Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.
    Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.
    Pediatr Nephrol; 2012 Nov; 27(11):2099-2106. PubMed ID: 22710694
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 Nov; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 11. Urinary biomarkers in hydronephrosis.
    Madsen MG.
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [Abstract] [Full Text] [Related]

  • 12. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [Abstract] [Full Text] [Related]

  • 13. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L, Pu X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z.
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [Abstract] [Full Text] [Related]

  • 15. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.
    Tomczak J, Wasilewska A, Milewski R.
    Pediatr Nephrol; 2013 Sep; 28(9):1863-9. PubMed ID: 23673972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children.
    McWilliam SJ, Antoine DJ, Sabbisetti V, Pearce RE, Jorgensen AL, Lin Y, Leeder JS, Bonventre JV, Smyth RL, Pirmohamed M.
    Biomark Med; 2014 Sep; 8(10):1189-97. PubMed ID: 24661102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
    Parmaksız G, Noyan A, Dursun H, İnce E, Anarat R, Cengiz N.
    Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.